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A b s t r a c t
Background: In Poland, together with the transformation of the political system, significant positive changes have been
made to the national health care system. This provided a possibility for hospitals to apply current standards of care to patients
with acute coronary syndromes (ACS).
Aim: To assess contemporary data on epidemiology, management and outcomes of patients with ACS in Poland, and to
evaluate adherence to the guidelines’ recommended treatment. 
Methods: We performed an observational study of 100,193 patients hospitalised due to unstable angina, non-ST-segment
elevation myocardial infarction (NSTEMI), or ST-segment elevation myocardial infarction (STEMI), prospectively enrolled in 417
hospitals from October 2003 to March 2006 in the ongoing Polish Registry of Acute Coronary Syndromes (PL-ACS). The registry
is carried out in cooperation with the Ministry of Health and the National Health Fund.
Results: The initial diagnoses were unstable angina in 42.2%, NSTEMI in 26.6%, and STEMI in 31.2% of patients. About one-third
of patients were treated outside of cardiology departments (mainly in the internal medicine wards). In patients without ST elevation,
invasive strategy (early coronary angiography) was used with almost equal frequency in unstable angina (29.4%) and NSTEMI
(31.7%). However, in-hospital mortality was low in unstable angina (0.8%), being much higher in NSTEMI patients (6.6%), 
(p <0.001). In STEMI reperfusion therapy was administered in 63.3% of patients (thrombolysis 7.8%, primary PCI 54.1%, and PCI after
thrombolysis 1.4%). In-hospital mortality in STEMI was 9.3%. Median times from the onset of symptoms to invasive treatment were:
37 hours in unstable angina, 23 hours in NSTEMI, and 5 hours in STEMI. The guidelines’ recommended pharmacotherapy was used
in a high percentage of patients except for thienopyridines and GP IIb/IIIa inhibitors. 
Conclusions: The Polish Registry of Acute Coronary Syndromes shows several discrepancies between guidelines’
recommended treatment and their utilisation in everyday practice. Particularly, the under-utilisation of invasive treatment in
patients with NSTEMI is alarming. Efforts should be made to increase the usage of invasive treatment in NSTEMI patients and
to shorten the delay from the symptom onset to intervention.
Key words: acute coronary syndromes, registry, epidemiology, in-hospital outcomes, invasive strategy, guidelines’ recommended
treatment
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Introduction
In recent years, considerable advances have been
made in the diagnosis and management of unstable
angina (UA), non-ST-segment elevation myocardial
infarction (NSTEMI), and ST-segment elevation
myocardial infarction (STEMI). However, acute coronary
syndromes (ACS) continue to be a significant health
problem in the industrialised world, being responsible for
a substantial number of deaths due to cardiovascular
diseases [1]. Several practice guidelines have been
developed in Europe and the US to improve outcomes of
ACS patients by implementation of the recommendations
into clinical practice [2-6]. However, it is well known
from surveys and registries performed so far that
epidemiology and management of ACS patients differ 
a lot between countries and that a wide gap exists
between guidelines and current clinical practice [7-10].
Additionally, many patients in several European
countries are hospitalised in internal medicine wards
instead of coronary care units or cardiology wards and
these patients are rarely adequately represented in the
registries. Finally, multinational registries do not
represent any real, existing geographical population,
instead they rather represent statistical averages for the
participating centres. Therefore, the need still exists for
national registries to collect substantial data on
a population-based principle.
In Poland, together with the transformation of the
political system, significant positive changes have been
made to the national health care system. This provided 
a possibility for hospitals to apply current standards of
care to ACS patients. Furthermore, once Poland became
a member of the European Union, the Polish Cardiac
Society recommend the ESC Guidelines to be in use in
Poland [2-4]. A nationwide registry of ACS had never been
conducted in Poland before. Thus, the Polish Registry of
Acute Coronary Syndromes (PL-ACS) was launched in late
2003 to assess contemporary data on epidemiology,
management and outcomes of ACS patients in Poland.
The present study summarises the main initial findings
from the PL-ACS Registry, presenting the clinical and
demographic characteristics of the patients, their
management, and in-hospital outcomes.
Methods
The PL-ACS Registry was a joint initiative of the
Silesian Centre for Heart Diseases in Zabrze and the
Ministry of Health of Poland. Logistic support was
obtained from the National Health Fund, which is
a nationwide, public health insurance institution in
Poland and which insurance policy is required for all
Polish citizens. The pilot phase of the Registry
commenced in October 2003 in Silesia, Poland. In the
following months, further regions were opened and
from June 2005 all Polish regions collected data for the
PL-ACS Registry.
Participating Centres
Out of all Polish hospitals, a total of 535 centres were
selected to be invited to enter the registry, based on the
following conditions: the centre (1) contains one of the
following wards in its structure: coronary care unit,
cardiology, cardiac surgery, internal medicine or intensive
care unit, or (2) does not have any of these wards but
hospitalises at least 10 ACS patients per year. The data
required for this selection were obtained from the
National Health Fund database. Sixty-six centres were
opened at the beginning of the programme and the
others entered the registry in subsequent months. Some
of the centres stopped collecting data while the registry
was running. Finally, the total number of centres
participating in the registry was 417 (Figure 1). Among
them, there were 59 (14%) centres with percutaneous
coronary intervention (PCI) facilities. In 3 out of 16
regions in Poland, data were obtained from all the
centres hospitalising patients with ACS. The percentage
of participating centres in the other regions ranged from
43% to 94% with a median value of 78% and
interquartile range of 72% to 85%. 
Patients
According to the protocol, all admitted patients
with suspected ACS were screened to be eligible to
enter the registry but the patients were not enrolled
until ACS was confirmed. Short stays for observation in
the admission room before transfer to another hospital
for management were not registered. The initial
diagnosis was made by the attending physician, based
on clinical presentation, initial electrocardiographic
pattern, and markers of myocardial necrosis acquired
at least 6 hours after the symptom onset. The patients
were then classified as having UA, NSTEMI, or STEMI.
The definition of the initial diagnosis (that affects
selection of treatment strategy) was as follows:
• STEMI: presence of: 1) ST-segment elevation
consistent with MI of ≥2 mm in adjacent chest leads
and/or ST-segment elevation of ≥1 mm in 2 or more
standard leads or new left bundle branch block, and
2) positive cardiac necrosis markers.
• NSTEMI: 1) absence of ST-segment elevation
consistent with MI of ≥2 mm in adjacent chest leads
and ST-segment elevation of ≥1 mm in 2 or more
standard leads and new left bundle branch block, and
2) positive cardiac necrosis markers.
862 Lech Poloński et al.
Kardiologia Polska 2007; 65: 8
• UA: 1) absence of ST-segment elevation consistent
with MI of ≥2 mm in adjacent chest leads and ST-
segment elevation of ≥1 mm in 2 or more standard
leads and new left bundle branch block, and
2) negative cardiac necrosis markers, and 3) angina
pectoris (or equivalent type of ischaemic discomfort)
with any one of the three following features: 
a) angina occurring at rest and prolonged, usually
greater than 20 minutes, b) new-onset angina of at
least CCS class III severity, or c) recent acceleration of
angina reflected by an increase in severity of at least
one CCS class to at least CCS class III.
If the patient was hospitalised during the same ACS
in more than one hospital (transferred patient), all
hospitals were required to complete the registry data.
These hospitalisations were linked together during
data management and were analysed as one ACS
Protocol and definitions
A detailed protocol was prepared before the registry
was started with inclusion and exclusion criteria, methods
and logistics, and definitions of all fields in the registry
dataset. However, it was amended twice. In May 2004,
the definitions were adapted to be compatible with the
Cardiology Audit and Registration Data Standards
(CARDS) [11]. Nevertheless, the PL-ACS Registry case
report form (CRF) covers only part of the CARDS dataset.
The second amendment was distributed to the hospitals
in May 2005 together with the addition of new fields to
the CRF. Finally, the registry CRF included 125 fields
regarding demographic, clinical, and electrocardiographic
characteristics of a patient, the diagnostic and treatment
modalities, and in-hospital outcomes. 
In-hospital complications were defined as follows:
• Myocardial infarction – ischaemic event that met the
ESC/ACC criteria for MI (for patients with initial
diagnosis of UA) or re-infarction (for patients
diagnosed initially as NSTEMI or STEMI) and was
evidently clinically distinct from the index event at the
time of admission [12].
• Stroke (haemorrhagic or ischaemic) – an acute
neurologic deficit that lasted more than 24 hours and
affected the ability to perform daily activities or
resulted in death.
• Major bleeding – overt clinical bleeding that 1) was
associated with a drop in haemoglobin of greater than
5 g/dl (0.5 g/l) or in haematocrit of greater than 15%
Polish Registry of Acute Coronary Syndromes (PL-ACS) 863
Figure 1. Cumulative numbers of enrolled patients and participating centres in successive months of
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(absolute), or 2) caused haemodynamic compromise,
or 3) required blood transfusion. 
Data collection
Data were collected by the skilled physicians who
were in charge of an individual patient. They were
entered either directly into electronic case report form
or a printed CRF was used temporarily before putting
data into the electronic CRF. We used dedicated
software based on the Excel worksheet (Microsoft, US).
Internal checks for missing or conflicting data and
values markedly out of the expected range were
implemented by the software. Once a month, the data
automatically were encoded and sent to the National
Health Fund, where they were additionally compared
with standard patients’ reports sent by the hospitals.
After that the National Health Fund sent the data to the
Silesian Centre for Heart Diseases, the data
management and analysis centre, and further edit
checks were applied. No site audits were required by
the protocol to be carried out in the participating
centres.
Statistical methods
Continuous variables are reported as means ±SD or
medians and interquartile ranges, as appropriate.
Categorical variables are expressed as percentages. 
In-hospital outcomes in different ACS categories were
compared using the chi-square test. All analyses were
performed according to the initial diagnosis. A two-sided
p value ≤0.05 was considered significant. For all
calculations, the STATISTICA 7.1 software (StatSoft, Inc.,
Tulsa, OK, USA) was used.
Results
From October 2003 to March 2006 a total of
108,302 completed CRFs for patients with ACS were
collected from 417 centres (78% of all invited). About
two-thirds of them were obtained for patients
hospitalised after May 2005 due to the opening of the
new centres (Figure 1). The median number of enrolled
patients per hospital was 130 with interquartile range
from 53 to 293. Because some patients were
transferred between hospitals and had duplicated
CRFs, the final number of patients with ACS was
100,193. The initial diagnoses for these patients were
UA in 42.2%, NSTEMI in 26.6%, and STEMI in 31.2%. 
Baseline demographic and clinical characteristics are
presented in Table I. Patients diagnosed with NSTEMI
were older than UA and STEMI patients. Unstable angina
and STEMI patients were of similar age. Females were
more frequently represented in UA (44.0%) than in
NSTEMI (40.9%) and STEMI (34.0%). Patients with NSTE-
-ACS had higher incidence of diabetes, hypertension,
hypercholesterolaemia, obesity, prior MI, and history of
PCI or CABG than STEMI patients, who were more likely
to be current smokers.
Haemodynamical and ECG findings on admission
are shown in Table II. Cardiac arrest before admission
most frequently developed in patients with STEMI (5%).
Systolic and diastolic blood pressures measured on
admission were the highest in UA and the lowest in
STEMI patients, although heart rate was the highest in
NSTEMI. Killip classes III or IV occurred with similar
frequency in NSTEMI and STEMI. However, cardiogenic
shock dominated in STEMI patients. Unstable angina
patients had low rates of severe haemodynamic
disturbances on admission. About 10-15% of patients
had other than sinus rhythm in admission ECG
records, with the highest incidence of atrial
fibrillation in the NSTEMI group. In these patients,
conduction abnormalities were also more often seen.
In NSTE-ACS, ST-segment depression was the most
frequently observed abnormality but ST-segment
elevation was also noted in 4.5%. About 16% of UA
and 7% of NSTEMI patients did not have any ST-T
changes in the initial ECG records.
The wards of the first and final hospitalisation of ACS
patients are presented in Table III. Both NSTE-ACS and
STEMI patients were initially admitted to cardiology or
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UA NSTEMI STEMI
(n=42 232) (n=26 663) (n=31 298)
Age [years] 64.9±11.0 68.0±11.8 64.0±12.4
≥75 years [%] 21.6 33.3 22.8
≥85 years [%] 2.1 5.4 3.8
Female gender [%] 44.0 40.9 34.0
Diabetes [%] 22.1 28.1 21.2
Current smoking [%] 21.5 24.7 39.1
Hypertension [%] 76.3 71.2 58.7
Hypercholesterolemia [%] 53.1 44.7 41.1
Obesity [BMI ≥30 kg/m2] [%] 21.4 20.0 16.8
Prior myocardial infarction [%] 30.6 28.1 15.6
Prior PCI [%] 5.8 3.2 1.4
Prior CABG [%] 11.9 7.1 4.9
Table I. Baseline demographic and clinical
characteristics of patients with ACS
Abbreviations: BMI – body mass index, CABG – coronary artery
bypass grafting surgery, NSTEMI – non-ST-segment elevation
myocardial infarction, PCI – percutaneous coronary intervention,
STEMI – ST-segment elevation myocardial infarction, UA – unstable
angina
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coronary care units in 60-70% of cases (in Poland, the
coronary care unit in most cases is a part of the
cardiology ward) whilst about one-third of the patients
were hospitalised in internal medicine wards. Some
patients were then transferred to cardiology wards
(mainly for invasive treatment). Finally, in the hospitals
with PCI facilities there were hospitalised 35% of UA,
39% of NSTEMI and 64% of STEMI patients. A small
minority of patients (2-5%) were treated in intensive
care units or other wards. Median duration of
hospitalisation was 6 days in UA (with interquartile
range of 4-8 days), 8 days (4-11) in NSTEMI, and 6 days
(4-9) in STEMI patients.
In-hospital management practices
Treatment practices during hospitalisation for ACS are
presented in Table IV. In the NSTE-ACS group, invasive
strategy (coronary angiography) was applied in about
UA NSTEMI STEMI
Cardiac arrest before admission [%] 0.3 2.0 5.0
Heart rate [beats/minute]* 75±15 81±19 78±18
Systolic blood pressure [mmHg]* 146±28 142±33 131±33
Diastolic blood pressure [mmHg]* 86±15 84±19 79±20
Killip class [%]
I 92.0 77.6 79.3
II 6.6 11.6 8.7
III 0.9 7.2 3.8
IV 0.5 3.6 8.2
Localisation of STEMI [%]
anterior – – 40.5
inferior – – 48.8
other – – 10.7
ECG rhythm* [%]
sinus 91.0 85.7 90.7
atrial fibrillation 6.4 9.9 6.2
pacemaker 1.4 1.3 0.5
other 1.2 3.1 2.6
ECG conduction abnormalities* [%]
normal 81.3 78.0 85.5
LBBB 5.1 7.1 2.5
RBBB 4.2 4.8 3.5
other 9.4 10.1 8.6
ECG ST-T changes [most severe]* [%]
normal 15.9 7.3 0.5
ST elevation 4.5 4.5 94.0
ST depression 33.3 46.6 1.6
pathological T inversion 18.2 20.1 1.9
other 28.1 21.5 2.0
Table II. Haemodynamical and ECG findings on
admission in patients with ACS
Abbreviations: see Table I
Continues variables are presented as mean ± SD





cardiology/CCU 60.7 62.8 70.5
with PCI facility 30.4 31.8 51.3
internal medicine 37.3 34.7 23.3
intensive care unit 0.4 1.3 1.6
other 1.6 1.2 4.6
Final ward
cardiology/CCU 63.2 67.2 77.6
with PCI facility 35.0 39.3 63.7
internal medicine 34.7 30.3 17.6
intensive care unit 0.4 1.2 1.6
other 1.7 1.3 3.2
Table III. First and final hospitalisation wards of
patients with ACS
Abbreviations: CCU – coronary care unit, others –  see Table I
UA NSTEMI STEMI
[%] [%] [%]
Thrombolysis alone 0.3 0.6 7.8
GP IIb/IIIa inhibitor 0.9 3.1 15.9
without invasive strategy 0.2 0.6 1.3
with invasive strategy 2.7 8.4 25.9
Coronary angiography 29.4 31.7 59.2
PCI for treatment of culprit lesion(s) 17.4 23.1 55.5
PCI after thrombolysis 0.6 0.7 2.6
PCI without preceding thrombolysis 99.4 99.3 97.4
bare metal stent 79.8 83.3 89.8
drug eluting stent 5.7 3.1 0.9
elective GP IIb/IIIa inhibitor 2.1 5.5 13.1
bailout GP IIb/IIIa inhibitor 1.6 4.3 11.8
final TIMI flow grade 3 95.9 91.8 90.6
Additional PCI for other significant 2.7 3.6 5.0
stenosis
IABP 0.1 0.4 1.1
CABG (during hospitalisation) 1.3 0.9 0.6
CABG (deferred) 5.2 4.7 3.9
Table IV. In-hospital treatment of patients with
ACS
Abbreviations: IABP – intra-aortic balloon pump, TIMI – thrombolysis
in myocardial infarction, others – see Table I 
30% of patients which gave a low rate of PCI in UA (29%)
and NSTEMI (32%). In STEMI, almost two-thirds of
patients had coronary angiography performed and nearly
all of them had subsequent PCI for treatment of the
culprit lesion in the infarct-related artery. Thrombolysis
was incidentally used in NSTE-ACS (<1%) mainly due to
in-hospital progression to STEMI. In STEMI patients,
thrombolysis was administered in 9.3% of patients
(in 7.8% as the only reperfusion therapy and in 1.5% with
subsequent PCI procedure). The most frequent reason
why thrombolysis was not given was intended primary
PCI (in 54.0%). The other reported reasons were late
presentation in 11.5%, other contraindications in 5.0%,
and other causes or unknown reasons in 29.5%.
Altogether, 63.3% of patients received reperfusion
therapy for STEMI.
The GP IIb/IIIa inhibitors were used in a small number
of patients with NSTE-ACS and in a minority of STEMI
patients (16%). In fact, these agents were given mostly to
patients who were treated invasively. In about 45% of
patients treated with PCI and receiving GP IIb/IIIa
inhibitor, this drug was used as a bailout therapy during
the procedure. Stents were implanted in 85-90% of PCI
procedures. The use of drug-eluting stents during PCI
varied from 5.7% in UA to 0.9% in STEMI patients. Intra-
-aortic balloon pump was used more frequently in STEMI
(1.1%) than in patients with NSTE-ACS (<0.5%). Coronary
artery bypass grafting surgery (CABG) was performed
during hospital stay in about 1% of patients and
additionally 4-5% of patients were qualified for deferred
CABG, more often in NSTE-ACS than in STEMI. 
Time delays
Symptom onset-to-admission time was shorter in
STEMI patients (median = 260 minutes, interquartile
range = 132-750 minutes) than in patients with NSTE-ACS,
in whom it was nearly twice as long (Table V). 
For STEMI patients, in-hospital delays in initiation of
reperfusion treatment were shorter for thrombolysis
(median = 25 minutes) than for primary PCI (median = 50
minutes). Three-fourths of patients received thrombolysis
in the first 45 minutes after admission and up to 6 hours
from the onset of symptoms, while three-fourths of
patients treated with PCI waited even up to 85 minutes
from admission and 10 hours from the onset of
symptoms for the first balloon inflation. 
Patients with NSTE-ACS had to wait longer after
admission to have PCI. In the UA group, the median
delay was about 12 hours (interquartile range = 2-40
hours) whereas in patients with NSTEMI it was
shorter (median = 3 hours) with the interquartile
range being wide, from one to 24 hours. 
In-hospital and discharge pharmacotherapy
The majority of patients received medical therapy that
is currently recommended by the guidelines (Figure 2).
The proportions of use were 92-93% for aspirin, 
72-82% for beta-blockers, 68-78% for ACE inhibitors, and
74-78% for statins. Unfractionated or low-molecular-
-weight heparins were given to 65-76% of patients. The
frequency of thienopyridine use was closely connected





















































































Figure 2. In-hospital medical therapy for
patients with acute coronary syndromes (white
bars – UA, grey – NSTEMI, black – STEMI) 
Abbreviations: ACE-I – angiotensin-converting enzyme inhibitor,
LMWH – low-molecular-weight heparin, NSTEMI – non-ST-
segment elevation myocardial infarction, STEMI – ST-segment
elevation myocardial infarction, UA – unstable angina
UA NSTEMI STEMI
[%] [%] [%]
Onset of symptoms  432 405 260
to admission (n=60 120) (169-1790) (160-1498) (132-750)
Admission to thrombolysis – – 25 
(n=1482) (15-45)
Onset of symptoms – – 185
to thrombolysis (n=1453) (115-350)
Admission to first balloon 683 180 50
inflation (n=17 380) (118-2405) (60-1429) (32-85)
Onset of symptoms to first 2240 1350 310
balloon inflation (n=16 810) (810-6315) (476-4310) (195-615)
Table V. Time delays in minutes (median,
interquartile range) in patients with ACS*
Abbreviations: see Table I 
* Detailed information was available since June 2005. Exact numbers
of patients are shown in parentheses
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with the rates of invasive treatment, and varied from 36%
in UA to 64% in STEMI patients. Calcium blockers and
nitrates were used more frequently in the NSTE-ACS
patients. 
Medical therapy prescribed to the patients at
discharge was very similar to the in-hospital
administration of these medications (Figure 3). The
proportion of statins was even higher (81-82%) but
aspirin was not prescribed in 14-15% of patients. At
discharge, for 6-8% of patients low-molecular-weight
heparin was continued. Diuretics were recommended in
20-30% of patients.
In-hospital outcomes
In-hospital outcomes are shown in Figure 4. Patients
with UA had a low number of complications and 
a composite outcome (death, myocardial infarction or
stroke) occurred in 1.3% of them. Usually analysed
together with UA as NSTE-ACS, NSTEMI patients had
several times worse outcome than UA patients. The
rates of complications were much closer to those
reported for STEMI patients. The NSTEMI patients had
lower mortality (6.6 vs. 9.3%, p <0.0001), higher rates of
recurrent MI (5.6 vs. 3.8%, p <0.0001), and similar
incidence of stroke (0.6 vs. 0.7%, p=0.057) in comparison
with STEMI patients. The composite outcome (death,
recurrent MI or stroke) was lower only by 1% in the
NSTEMI group (11.9%) than in the STEMI patients
(p <0.0001).
Discussion
The PL-ACS registry is one of the largest national
registries of ACS in Europe, providing the most current
data on demography, treatment and outcomes of
100,000 patients in one European Union country. Being
designed as a population-based registry, it managed to
enrol patients from 78% of Polish centres that deal with
ACS. Importantly, the academic or large centres were not
favoured in order to obtain the most authentic picture of
current practice. Furthermore, while one-fourth of the
patients in PL-ACS were older than 75 years, and 40%
were women, the registry covers a large part of the
population that had usually been under-represented in
randomised trials. Thus, the PL-ACS Registry could help in
providing answers to many current issues in ACS.
At first, comments should be made on distribution of
the initial diagnosis of ACS. In the PL-ACS registry, more
than 40% of patients were initially diagnosed as having
UA. The others were diagnosed as having MI, with
slightly more STEMI (31%) than NSTEMI (27%). The
recent data from Europe show a lower proportion of UA
among ACS patients [7, 13]. Thus, it is possible that some
of the patients were overdiagnosed because the criteria
for UA were rather liberal and did not require ECG
changes. In fact, typical ischaemic ECG abnormalities
were present only in about 60% of UA patients. However,
they were managed as UA patients with all the ensuing
consequences.
One of the unresolved problems in managing patients
with ACS is that a significant number of them are
hospitalised in non-cardiology wards (mostly internal
medicine ones), where accessibility to recommended
treatment is limited [7, 14]. In Poland, it takes place in
one-third of NSTE-ACS and about one-fifth of STEMI
patients, even after inter-hospital transfer. This means
that every fourth patient with ACS is treated by a non-
-cardiology specialised team of physicians.



















































































Figure 3. Medications prescribed at discharge
for surviving patients with ACS (white bars – UA,
grey – NSTEMI, black – STEMI)





















Figure 4. In-hospital outcomes of ACS* (white
bars – UA, grey – NSTEMI, black – STEMI)
Abbreviations: MI – myocardial infarction; others – see Figure 2
* p <0.001 for all pair comparisons except for stroke in NSTEMI vs.
STEMI where p=0.06
death MI stroke death/MI death/MI/
stroke
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Adherence to guidelines’ recommended
treatment
Unstable angina
About one-third of patients with UA were hospitalised
in centres with PCI facilities and had coronary angiography
performed. In 65% of them PCI or CABG during index
hospitalisation were performed. In UA, guidelines
recommend early invasive strategy only in high-risk
patients [2, 4]. In view of that, the proportion of
revascularisation could be satisfactory compared with
the European part of the GRACE (Global Registry of Acute
Coronary Events) registry (coronary angiography in 37%,
of which 65% were revascularised) [13]. Additionally,
although in the outside-Europe GRACE dataset the rate of
coronary angiography was 50%, the percentage of
subsequent revascularisations was lower (56%), being
similar to the European data in absolute numbers [13]. 
In-hospital usage of the guidelines’ recommended
medical therapy was high in UA and even higher than in
the NSTEMI and STEMI patients, being also higher than
in GRACE [13]. Similar trends were observed in
medications prescribed at discharge. However,
thienopyridines were given mainly together with
invasive treatment and were rarely used with non-
invasive strategy, which resulted in their low usage.
Non-ST-segment elevation myocardial infarction
Current guidelines link together UA and NSTEMI 
in NSTE-ACS, even though there are substantial
differences in outcomes between these two types of
ACS [2, 4-5]. We found that management of NSTEMI
was very similar to UA but the outcomes were much
closer to STEMI patients. Only 40% of NSTEMI patients
were hospitalised in PCI centres and no more than one-
fourth were revascularised. Unfortunately, comparable
trends were also observed in the other registries [7-8,
13, 15]. Thus, efforts should be made to shift the
invasive approach to high-risk NSTE-ACS patients and
to shorten the delay from symptom onset to
intervention.
In-hospital and discharge usage of the guidelines’
recommended medical therapy was high except for
thienopyridines and GP IIb/IIIa inhibitors. At the time of
the study, GP IIb/IIIa inhibitors were not refunded by
the National Health Fund for patients with NSTE-ACS
during the enrolment period, which undoubtedly
determined their low usage.
ST-segment elevation myocardial infarction 
and reperfusion treatment
Primary reperfusion therapy was received by 63.3%
of patients with STEMI. Compared to the EHS ACS-II
(Second Euro Heart Survey on Acute Coronary
Syndromes) registry (63.9%) [8] and the European part
of the GRACE registry (65%) [13], Poland represents an
average country in Europe, although with a higher
proportion of primary PCI to thrombolysis (6 to 1).
However, one-third of patients did not receive
reperfusion treatment. The median time from
admission to reperfusion was still much shorter for
thrombolysis, but the median absolute difference was
only 25 minutes. 
Guidelines’ recommended medical treatment
prescribed at discharge was acceptably high but in-
-hospital use of beta-blockers and ACE inhibitors was
lower than in the NSTE-ACS patients. The use of GP
IIb/IIIa inhibitors was relatively low in invasively treated
patients as compared to recent data from the registries
[8, 13]. 
In-hospital outcomes 
In-hospital mortality of patients with STEMI was
slightly higher as compared to the GRACE and EHS
ACS-II registries [8, 13]. The possible reason for that is
the more population-based approach of the PL-ACS
registry, with a large number of small, non-cardiology-
-specialised hospitals included. Patients with NSTEMI
had lower in-hospital mortality. However, the incidence
of recurrent infarction was higher in NSTEMI than
STEMI patients, probably due to a lower rate of invasive
treatment. The proportion of patients suffering from
stroke was low. This overall resulted in a comparable
combined outcome (death, recurrent MI or stroke) in
NSTEMI and STEMI. Unstable angina patients had 
a favourable combined outcome (1.3%).
Limitations
Although the PL-ACS registry has a population-
based approach, the proportion of participating centres
was 78% and selection bias could have occurred.
Additionally, not all contributing hospitals enrolled
patients through all the duration of the registry. Finally,
the data come from one country, which probably is not
representative of the general population of patients
with ACS and of the hospitals admitting these patients
in other countries and continents. Therefore, the
results of this registry should be generalised with
caution to other countries or regions. Because site
audits were not routinely performed, we were unable to
check if the initial diagnosis was correctly established.
At present, we do not report follow-up data and all
findings concerning the outcomes should be
interpreted with caution. 
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Conclusions
The Polish Registry of Acute Coronary Syndromes,
with a large number of enrolled patients from more than
four hundred hospitals, provides reliable data on current
medical practice in one of the largest countries of the
European Union. It shows several discrepancies between
guidelines’ recommended treatment and their utilisation
in everyday practice. Particularly, the under-utilisation of
invasive treatment in patients with NSTEMI and
application of invasive procedures to patients with 
a lower risk profile is alarming. Efforts should be made to
shift the invasive burden to NSTEMI patients and to
shorten the delay from symptom onset to intervention. 
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APPENDIX
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S t r e s z c z e n i e
Wstęp: Wraz z transformacją systemu politycznego w Polsce zreformowany został również system opieki zdrowotnej. Dzięki
temu zwiększyła się dostępność w szpitalach do nowoczesnych, aktualnie obowiązujących sposobów leczenia ostrych zespołów
wieńcowych (OZW).
Cel: Zebranie aktualnych danych o epidemiologii, sposobie leczenia i rokowaniu chorych z OZW w Polsce oraz ocena
zgodności stosowanej strategii leczenia z wytycznymi. 
Metodyka: Do analizy włączono 100 193 chorych hospitalizowanych z powodu niestabilnej choroby wieńcowej, zawału serca
bez uniesienia odcinka ST (NSTEMI) oraz zawału serca z uniesieniem odcinka ST (STEMI), prospektywnie włączanych w 417
szpitalach w okresie od października 2003 do marca 2006 r. do Ogólnopolskiego Rejestru Ostrych Zespołów Wieńcowych PL-ACS. 
Rejestr jest realizowany we współpracy z Ministerstwem Zdrowia i Narodowym Funduszem Zdrowia. 
Wyniki: Z łącznej liczby chorych 42,2% było hospitalizowanych z powodu niestabilnej choroby wieńcowej, 26,6% z powodu
NSTEMI, a 31,2% z powodu STEMI. Około 1/3 chorych była leczona na oddziałach innych niż kardiologiczne (głównie na
oddziałach chorób wewnętrznych). W OZW bez uniesienia odcinka ST strategię inwazyjną (wczesną koronarografię) stosowano 
podobnie często w niestabilnej chorobie wieńcowej (29,4%) i w NSTEMI (31,7%). Tym niemniej śmiertelność wewnątrzszpitalna 
była niska w niestabilnej chorobie wieńcowej (0,8%) w porównaniu z 6,6% w NSTEMI (p <0,0001). W STEMI terapię reperfuzyjną
zastosowano u 63,3% chorych (trombolizę – u 7,8%, pierwotną angioplastykę wieńcową – u 54,1%, angioplastykę po leczeniu
fibrynolitycznym – u 1,4%). Śmiertelność wewnątrzszpitalna w STEMI wyniosła 9,3%. Mediana czasu od pojawienia się objawów
do leczenia inwazyjnego wyniosła 37 godz. w niestabilnej chorobie wieńcowej, 23 godz. w NSTEMI i 5 godz. w STEMI. Zalecana przez
wytyczne farmakoterapia była stosowana u wysokiego odsetka chorych, z wyjątkiem tienopirydyn i blokerów receptora GP IIb/IIIa. 
Wnioski: Ogólnopolski Rejestr Ostrych Zespołów Wieńcowych wskazuje, iż wiele zalecanych przez wytyczne sposobów 
postępowania w OZW nie jest odpowiednio często realizowanych w praktyce klinicznej. Szczególnie niepokojący jest niski
odsetek leczenia inwazyjnego chorych z NSTEMI. Należy podjąć działania, aby zwiększyć odsetek chorych z NSTEMI leczonych
inwazyjnie oraz skrócić czas od wystąpienia objawów do interwencji. 
Słowa kluczowe: ostre zespoły wieńcowe, rejestr, epidemiologia, rokowanie wewnątrzszpitalne, wytyczne 
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